Daclizumab Subcutaneous and Zoledronic acid Intravenous
Determining the interaction of Daclizumab Subcutaneous and Zoledronic acid Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Zoledronic Acid IV
- Daclizumab Subcutaneous-Zolgensma
- Daclizumab Subcutaneous-Zolinza
- Daclizumab Subcutaneous-Zolmitriptan
- Daclizumab Subcutaneous-Zolmitriptan nasal
- Daclizumab Subcutaneous-Zolmitriptan Nasal Spray
- Zoledronic acid Intravenous-Dacogen
- Zoledronic acid Intravenous-Dacomitinib
- Zoledronic acid Intravenous-Dactinomycin
- Zoledronic acid Intravenous-Dactinomycin Injection
- Zoledronic acid Intravenous-Dactinomycin Intravenous
- Zoledronic acid Intravenous-Daklinza